David Larsen
Stock Analyst at BTIG
(0.26)
# 4,272
Out of 4,476 analysts
571
Total ratings
36.4%
Success rate
-3.5%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintained: Buy | $65 → $90 | $69.03 | +30.38% | 17 | Jun 22, 2026 | |
| SLP Simulations Plus | Rated: Hold | $19 | $18.39 | +0.60% | 18 | Jun 16, 2026 | |
| HSIC Henry Schein | Upgraded: Buy | $100 | $86.43 | +15.70% | 14 | Jun 11, 2026 | |
| MDLN Medline | Reiterated: Buy | $55 | $43.19 | +27.34% | 5 | Jun 9, 2026 | |
| TOI The Oncology Institute | Maintained: Buy | $7 → $8 | $5.28 | +51.52% | 10 | Jun 8, 2026 | |
| VEEV Veeva Systems | Rated: Buy | $340 | $192.74 | +76.40% | 13 | Jun 3, 2026 | |
| ASTH Astrana Health | Rated: Buy | $40 → $50 | $49.17 | +1.69% | 14 | Jun 2, 2026 | |
| HQY HealthEquity | Maintained: Buy | $110 | $95.31 | +15.41% | 30 | May 28, 2026 | |
| DOCS Doximity | Downgraded: Hold | n/a | $21.86 | - | 12 | May 14, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | n/a | $2.08 | - | 25 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.5556 | - | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $30.22 | -0.73% | 18 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.7797 | - | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $12 | $11.27 | +6.48% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.87 | +105.34% | 43 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $17 | $15.49 | +9.75% | 30 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.25 | - | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.20 | - | 19 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $43.03 | - | 25 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $36.80 | - | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $5.71 | +40.11% | 50 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $40 | $37.94 | +5.43% | 11 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $207.04 | - | 11 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.37 | - | 10 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $111.01 | - | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $27.36 | n/a | 15 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 16 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $296.51 | n/a | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $230.69 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $104.72 | n/a | 28 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $65 → $55 | $238.94 | n/a | 12 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $9 | $3.59 | n/a | 6 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $160 | $786.30 | n/a | 11 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $13 | $5.10 | n/a | 8 | Jun 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 → $25 | $26.24 | n/a | 5 | Nov 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | - | n/a | 3 | Nov 3, 2016 |
BrightSpring Health Services
Jun 22, 2026
Maintained: Buy
Price Target: $65 → $90
Current: $69.03
Upside: +30.38%
Simulations Plus
Jun 16, 2026
Rated: Hold
Price Target: $19
Current: $18.39
Upside: +0.60%
Henry Schein
Jun 11, 2026
Upgraded: Buy
Price Target: $100
Current: $86.43
Upside: +15.70%
Medline
Jun 9, 2026
Reiterated: Buy
Price Target: $55
Current: $43.19
Upside: +27.34%
The Oncology Institute
Jun 8, 2026
Maintained: Buy
Price Target: $7 → $8
Current: $5.28
Upside: +51.52%
Veeva Systems
Jun 3, 2026
Rated: Buy
Price Target: $340
Current: $192.74
Upside: +76.40%
Astrana Health
Jun 2, 2026
Rated: Buy
Price Target: $40 → $50
Current: $49.17
Upside: +1.69%
HealthEquity
May 28, 2026
Maintained: Buy
Price Target: $110
Current: $95.31
Upside: +15.41%
Doximity
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $21.86
Upside: -
Health Catalyst
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $2.08
Upside: -
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.5556
Upside: -
May 11, 2026
Maintained: Buy
Price Target: $30
Current: $30.22
Upside: -0.73%
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $0.7797
Upside: -
May 8, 2026
Maintained: Buy
Price Target: $11 → $12
Current: $11.27
Upside: +6.48%
May 7, 2026
Reiterated: Buy
Price Target: $10
Current: $4.87
Upside: +105.34%
May 5, 2026
Maintained: Buy
Price Target: $15 → $17
Current: $15.49
Upside: +9.75%
May 5, 2026
Maintained: Hold
Price Target: n/a
Current: $9.25
Upside: -
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $9.20
Upside: -
Apr 28, 2026
Maintained: Hold
Price Target: n/a
Current: $43.03
Upside: -
Mar 5, 2026
Maintained: Hold
Price Target: n/a
Current: $36.80
Upside: -
Feb 25, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $5.71
Upside: +40.11%
Feb 17, 2026
Maintained: Buy
Price Target: $37 → $40
Current: $37.94
Upside: +5.43%
Feb 5, 2026
Maintained: Hold
Price Target: n/a
Current: $207.04
Upside: -
Nov 14, 2025
Rated: Hold
Price Target: n/a
Current: $11.37
Upside: -
Nov 4, 2025
Rated: Hold
Price Target: n/a
Current: $111.01
Upside: -
Mar 5, 2025
Maintained: Buy
Price Target: $35
Current: $27.36
Upside: n/a
Jun 23, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $296.51
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $230.69
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $104.72
Upside: n/a
Nov 16, 2018
Downgraded: Hold
Price Target: $65 → $55
Current: $238.94
Upside: n/a
Oct 31, 2018
Maintained: Hold
Price Target: $17 → $9
Current: $3.59
Upside: n/a
May 29, 2018
Reiterated: Hold
Price Target: $170 → $160
Current: $786.30
Upside: n/a
Jun 19, 2017
Downgraded: Hold
Price Target: $17 → $13
Current: $5.10
Upside: n/a
Nov 4, 2016
Maintained: Hold
Price Target: $26 → $25
Current: $26.24
Upside: n/a
Nov 3, 2016
Reiterated: Hold
Price Target: $9
Current: -
Upside: n/a